Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Provided By Globe Newswire

Last update: Apr 3, 2023

- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals